What Happened to Hims & Hers Health?
Ticker: HIMSSPAC Year: 2020Merger: 2021
Return
+320.0%
Current Price
$42
Peak Price
$55
Trust Size
$280M
Summary
Telehealth and wellness company â THE SPAC success story. Stock went from $10 to $55 with real revenue growth, profitability, and a genuine disruption of healthcare delivery.
What Happened
Hims & Hers merged with Oaktree Acquisition Corp in January 2021. The company sells telehealth consultations and prescription treatments (hair loss, ED, skincare, mental health) directly to consumers via subscription. Unlike nearly every other SPAC, Hims actually had product-market fit, efficient customer acquisition via social media, and a clear path to profitability. Revenue grew from $272M (2021) to $1.5B+ (2025). The stock hit $55 â making early SPAC investors 5x their money. The rare proof that the SPAC model can work with the right company.
Key People
Timeline
2020-09
SPAC merger announced
2021-01
Merger completed
2022-06
Stock dips to $4 (market downturn)
2023-12
GLP-1 weight loss treatments boost stock
2025-01
Stock hits $55, $12B market cap